decreased susceptibility to viral infection induced morbidity/mortality_Fgl2<tm1Pam>/Fgl2<tm1Pam>

http://metadb.riken.jp/0009790I129X1SvJC57BL6Fgl2tm1PamFgl2tm1PamFgl2tm1Pam

decreased susceptibility to viral infection induced morbidity/mortality_Fgl2<tm1Pam>/Fgl2<tm1Pam>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• fibrinogen-like protein 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:103266

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Fgl2<tm1Pam>/Fgl2<tm1Pam>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Fgl2<tm1Pam>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129X1/SvJ * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased susceptibility to viral infection induced morbidity/mortality
  http://purl.obolibrary.org/obo/MP_0009790

文献

http://purl.org/net/cito/citesAsAuthority

• Philip A. Marsden, et.al., The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis., The Journal of clinical investigation, 2003, 112
  http://rdf.ncbi.nlm.nih.gov/pubmed/12840059